Date:                9/14/2016

Contact: dave@blueskinsolutions.com

Statement on UN High-Level Panel on Access to Medicines Final Report

US Inventor is disappointed with the recommendations in the final report by the UN High-Level Panel on Access to Medicines (HLP). As shown by the lack of consensus in their report, this process missed an important moment to bring stakeholders together for identifying real, coherent, and sustainable solutions for increasing access to healthcare technologies.

The HLP’s original premise and final report singles out inventors’ rights as part of an incoherent system for access to healthcare. We propose the opposite. Inventors develop solutions to seemingly impossible challenges, drive innovation, and create new products for people around the world. Much of this work is supported by intellectual property rules that respect the ingenuity, perseverance, and investment made by individual inventors.

The HLP report even admits its narrow scope on IP is not adequate to cover the numerous healthcare challenges seen around the world. Therefore, US Inventor respectfully requests this report not be the basis for future U.S. or international policy analysis.

About US Inventor:

Building a community of innovators today to protect the inventors of tomorrow. Innovation is the cornerstone of the American Dream. Everyone can build the next best mousetrap. US Inventor’s vision is to help teach people that process as well defending that ability on Capitol Hill. usinventor.org

US Inventor op ed on UN HLP here: Investor’s Business Daily